Drug intelligence / Profile preview

n-cyclohexyl-n'-(propyl)phenyl urea

Development stage: Unknown
Modality: Small Molecules
Administration: Not Applicable (experimental/research Use Only)

Overview

N-Cyclohexyl-N'-(Propyl)Phenyl Urea is a synthetic small molecule belonging to the class of benzene and substituted derivatives. It acts as an experimental inhibitor of bifunctional epoxide hydrolase 2 (also known as soluble epoxide hydrolase, sEH), an enzyme involved in the metabolism of endogenous lipid signaling molecules. By inhibiting this enzyme, the compound may modulate inflammation and vascular function, though it has not been approved for any clinical use or indication. The compound is primarily used in research settings to study epoxide hydrolase biology[1][4][5].

Other names: n-cyclohexyl-n'-(propyl)phenyl urea1-cyclohexyl–3-(3–phenylpropyl)urea

Targets

EPHX2 (Soluble epoxide hydrolase)

Beyond the preview

Go deeper on n-cyclohexyl-n'-(propyl)phenyl urea.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on n-cyclohexyl-n'-(propyl)phenyl urea.

Explore the full profile